Browse All Treatments

Showing 1856 records.


Page 44 of 186 1 42 43 44 45 46 186
Order by:
SurvivalPatientsToxicityTreatmentHospitalCountryDate
43118.8 monthsHormone-refractory prostate cancer4ChemotherapyUniversity of Athens School of MedicineGreeceJan 2004
Treatment Details: Patients: This Phase II study involved 38 patients with hormone refractory prostate cancer. Patients were divided into two groups: Group 1 and Group 2. The average age of patient... read more
43218.8 monthsAdvanced, Recurrent Ovarian Cancer4ChemotherapyUniversity General Hospital of HeraklionGreeceApr 2014
Treatment Details: Patients: This phase 2 study involved 23 advanced, platinum-sensitive, recurrent ovarian cancer patients who had been previously treated. The median patient age was 62.0 years. ... read more
43318.7 monthsHormone-refractory prostate cancer4ChemotherapyUniversity Hospital Hamburg-EppendorfGermanyJan 2006
Treatment Details: Patients: This Phase II study involved 34 men with hormone refractory prostate cancer. The median age was 67 years. Previous therapies included surgery (13 patients), radiation (... read more
43418.7 monthscolorectal (metastatic)4ChemotherapyHopital Huriez (CHRU)FranceMar 2006
Treatment Details: Patients: This Phase II trial involved a total of 39 patients with metastatic colorectal cancer. For 29 patients the site of the primary tumor was in the colon. For 9 patients it... read more
43518.7 monthscolorectal (metastatic)4ChemotherapyHopital Huriez (CHRU)FranceMar 2006
Treatment Details: Patients: This Phase II trial involved a total of 39 patients with metastatic colorectal cancer. For 29 patients the site of the primary tumor was in the colon. For 9 patients it... read more
43618.7 monthsMetastatic hormone-refractory prostate cancer3Chemotherapy, Gene TherapyVancouver Cancer CentreCanadaDec 2001
Treatment Details: Patients: This Phase I dose-finding study involved 26 patients with metastatic hormone-refractory prostate cancer. The median age was 69 and the median PSA was 135 (ranged from 30... read more
43718.6 monthsNewly diagnosed GBM4Chemotherapy, RadiationIstituto Nazionale Neurologico Carlo BestaItalyDec 2002
Treatment Details: Patients: This study involved 30 newly diagnosed patients with glioblastoma. The patients were divided into two groups (A and B) of 15 patients each. Treatment: Patients in Gro... read more
43818.6 monthsHormone refractory prostate cancer4ChemotherapyGeorges Pompidou European HospitalFranceMay 2005
Treatment Details: Patients: This Phase II study enrolled 130 men, who were randomized into three groups. Group A had 44 men (median age 68) with hormonal-resistant prostate cancer. For all patient... read more
43918.6 monthsMetastatic, castration-resistant prostate cancer4ChemotherapyRoyal Marsden HospitalUnited KingdomMay 2012
Treatment Details: Patients: This phase 2 study involved 108 metastatic castration-resistant prostate cancer patients with a median age of 71 years. Treatment: Patients were treated with the che... read more
44018.6 monthsmetastatic melanoma4Chemotherapy, ImmunotherapyTel Aviv-Sourasky Medical CenterIsraelFeb 2006
Treatment Details: Patients: This phase II study involved 23 patients with advanced inoperable melanoma, none of whom had been exposed to previous chemotherapy. Patients included 14 men and 9 women ... read more
Page 44 of 186 1 42 43 44 45 46 186